Marshall Wace
OCDX

Marshall Wace’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Marshall Wace’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-92,388
Closed -$1.73M – 4064
2022
Q1 		$1.73M Buy
92,388
+73,748
+396% +$1.33M ﹤0.01% 2146
2021
Q4 		$398K Buy
+18,640
New +$367K ﹤0.01% 2914

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marshall Wace's OCDX Position: Q2 2022 in Review

Marshall Wace sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 92,388 shares — an estimated $1.73M sold.

Marshall Wace first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.73M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Marshall Wace reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Marshall Wace sold 92,388 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.73M.
  • Marshall Wace first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Marshall Wace's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.73M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.